Crossmark

Ginsenoside Rh1 inhibits tumor growth in MDA-MB-231 breast cancer cells via mitochondrial ROS and ER stress-mediated signaling pathway

Published Online: 2022-03-24

Published Print: 2022-03

Authors

Jin, Yujin

Huynh, Diem Thi Ngoc

Heo, Kyung-Sun https://orcid.org/0000-0003-3800-7665
Funding

Funding for this research was provided by:

National Research Foundation of Korea (2017R1A4A1015860)

National Research Foundation of Korea (2019R1C1C100733112)
License Information

Text and Data Mining valid from 2022-03-01

Version of Record valid from 2022-03-01
More Information

Article History

Received: 12 January 2022

Accepted: 14 March 2022

First Online: 24 March 2022

Declarations

:

: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Document is current